ES8304945A1 - Substituted pyrimidin-2-ones and the salts thereof. - Google Patents
Substituted pyrimidin-2-ones and the salts thereof.Info
- Publication number
- ES8304945A1 ES8304945A1 ES508593A ES508593A ES8304945A1 ES 8304945 A1 ES8304945 A1 ES 8304945A1 ES 508593 A ES508593 A ES 508593A ES 508593 A ES508593 A ES 508593A ES 8304945 A1 ES8304945 A1 ES 8304945A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- ring
- heterocyclic
- hydrogen atom
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical class OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 101100134922 Gallus gallus COR5 gene Proteins 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000029936 alkylation Effects 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000006798 ring closing metathesis reaction Methods 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Compounds of the general formula: < IMAGE > I (wherein X represents a halogen atom or a trifluoromethyl group R1 and R2 independently represent a hydrogen atom or a lower alkyl group Z is -O-, -S-, -SO-, -SO2- or the group -NR4- wherein R4 is as defined for R hereinafter or represents the group COR5 in which R5 represents a hydrogen atom or an optionally substituted aryl, heterocyclic, aralkyl, lower alkyl or lower alkoxy group R represents a C6-10 carbocyclic aromatic group or a heterocyclic group containing a 5-9 membered unsaturated or aromatic heterocyclic ring which ring contains one or more heteroatoms selected from O, N and S and optionally carries a fused ring which carbocyclic or heterocyclic group may carry one or more C1-4 alkyl or phenyl groups, said groups being optionally substituted or, where Z represents the group >NR4, the group -ZR may represent a heterocyclic ring optionally carrying a fused ring and/or optionally substituted as defined for R and R3 represents a hydrogen atom or a lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower alkenoyl, C7-16 aralkyl or C6-10 arly group or a 5-9 membered unsaturated or aromatic heterocyclic ring) and, where acid or basic groups are present, the salts thereof are useful in combating abnormal cell proliferation. The compounds of the invention are prepared by inter alia alkylation, ring closure and oxidation.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8100613 | 1981-01-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES508593A0 ES508593A0 (en) | 1983-03-16 |
| ES8304945A1 true ES8304945A1 (en) | 1983-03-16 |
Family
ID=10518891
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES508593A Expired ES8304945A1 (en) | 1981-01-09 | 1982-01-08 | Substituted pyrimidin-2-ones and the salts thereof. |
| ES517865A Granted ES517865A0 (en) | 1981-01-09 | 1982-12-01 | A PROCEDURE FOR THE PREPARATION OF PIRIMIDIN-2-ONAS-SUBSTITUTED. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES517865A Granted ES517865A0 (en) | 1981-01-09 | 1982-12-01 | A PROCEDURE FOR THE PREPARATION OF PIRIMIDIN-2-ONAS-SUBSTITUTED. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US4596870A (en) |
| EP (1) | EP0056319B1 (en) |
| JP (1) | JPS57136575A (en) |
| AT (1) | ATE19242T1 (en) |
| AU (1) | AU7929482A (en) |
| CA (1) | CA1180710A (en) |
| DE (1) | DE3270525D1 (en) |
| DK (1) | DK5382A (en) |
| ES (2) | ES8304945A1 (en) |
| NO (1) | NO160514C (en) |
| NZ (1) | NZ199447A (en) |
| ZA (1) | ZA82125B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58159479A (en) * | 1982-02-24 | 1983-09-21 | ニユエガ−ド・アンド・コンパニ−・アクシエ／セルカペト | Substituted pyrimidin-2-one compound |
| GB2135992B (en) * | 1983-01-11 | 1986-09-24 | Nyegaard & Co As | Substituted pyrimidines and processes for their preparation |
| EP0119457B1 (en) * | 1983-02-23 | 1986-12-30 | Bayer Ag | Agent for regulating the growth of plants |
| GB8411291D0 (en) * | 1984-05-02 | 1984-06-06 | Nyegaard & Co As | Chemical compounds |
| US4864021A (en) * | 1984-10-30 | 1989-09-05 | Otsuka Pharmaceutical Co., Ltd. | 5-fluorouracil derivatives |
| US4675321A (en) * | 1986-02-07 | 1987-06-23 | Merck & Co., Inc. | Substituted pyrimidines useful as calcium channel blockers |
| US4849426A (en) * | 1987-05-15 | 1989-07-18 | Pearlman Dale L | Method for treating actinic keratosis with cytotoxic agents |
| US4853388A (en) * | 1987-05-15 | 1989-08-01 | Pearlman Dale L | Method for treating psoriasis with cytotoxic agents |
| US4820711A (en) * | 1987-05-15 | 1989-04-11 | Pearlman Dale L | Method for treating actinic keratosis with cytotoxic agents |
| US8933239B1 (en) * | 2013-07-16 | 2015-01-13 | Dow Global Technologies Llc | Bis(aryl)acetal compounds |
| GB201321734D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1561290A (en) * | 1975-10-16 | 1980-02-20 | Nyegaard & Co As | Pyrimid - 2 - ones |
| US4044008A (en) * | 1976-10-06 | 1977-08-23 | Morton-Norwich Products, Inc. | 1-[2-Hydroxy-3-(2-naphthoxy)propyl]-2(1H)pyrimidone hydrochloride |
| ES498337A0 (en) * | 1980-01-07 | 1982-06-01 | Nyegaard & Co As | A PROCEDURE FOR THE PREPARATION OF 5-HALO-PIRIMIDIN-2- ONAS |
| ES8205782A1 (en) * | 1980-01-10 | 1982-08-01 | Nyegaard & Co As | Pyrimidine-2-sulphides and their S-oxides for use in medicine, pharmaceutical compositions containing them, processes for their preparation and such compounds when novel per se. |
| JPS58159479A (en) * | 1982-02-24 | 1983-09-21 | ニユエガ−ド・アンド・コンパニ−・アクシエ／セルカペト | Substituted pyrimidin-2-one compound |
-
1982
- 1982-01-08 EP EP82300106A patent/EP0056319B1/en not_active Expired
- 1982-01-08 DK DK5382A patent/DK5382A/en not_active Application Discontinuation
- 1982-01-08 CA CA000393785A patent/CA1180710A/en not_active Expired
- 1982-01-08 AU AU79294/82A patent/AU7929482A/en not_active Abandoned
- 1982-01-08 ZA ZA82125A patent/ZA82125B/en unknown
- 1982-01-08 AT AT82300106T patent/ATE19242T1/en not_active IP Right Cessation
- 1982-01-08 ES ES508593A patent/ES8304945A1/en not_active Expired
- 1982-01-08 US US06/337,988 patent/US4596870A/en not_active Expired - Fee Related
- 1982-01-08 DE DE8282300106T patent/DE3270525D1/en not_active Expired
- 1982-01-08 NZ NZ199447A patent/NZ199447A/en unknown
- 1982-01-08 NO NO820049A patent/NO160514C/en unknown
- 1982-01-08 JP JP57001098A patent/JPS57136575A/en active Pending
- 1982-12-01 ES ES517865A patent/ES517865A0/en active Granted
-
1986
- 1986-04-08 US US06/849,271 patent/US4705791A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU7929482A (en) | 1982-07-15 |
| EP0056319A2 (en) | 1982-07-21 |
| ES508593A0 (en) | 1983-03-16 |
| ES8405771A1 (en) | 1984-06-16 |
| DE3270525D1 (en) | 1986-05-22 |
| NO160514B (en) | 1989-01-16 |
| ES517865A0 (en) | 1984-06-16 |
| EP0056319A3 (en) | 1982-10-27 |
| NZ199447A (en) | 1985-08-16 |
| NO160514C (en) | 1989-04-26 |
| DK5382A (en) | 1982-07-10 |
| US4705791A (en) | 1987-11-10 |
| US4596870A (en) | 1986-06-24 |
| CA1180710A (en) | 1985-01-08 |
| JPS57136575A (en) | 1982-08-23 |
| NO820049L (en) | 1982-07-12 |
| ATE19242T1 (en) | 1986-05-15 |
| ZA82125B (en) | 1982-12-29 |
| EP0056319B1 (en) | 1986-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO823836L (en) | PROCEDURE FOR THE PREPARATION OF ANTIFIBRINOLYTIC ACTIVE COMPOUNDS. | |
| ES8405771A1 (en) | Substituted pyrimidin-2-ones and the salts thereof. | |
| ES475635A1 (en) | Imidazole derivatives | |
| ES462671A1 (en) | alpha -(4-Biphenylyl)-benzyl-azolium salts and their use for combating micro-organisms | |
| DE3371512D1 (en) | Substituted pyrimidin-2-ones and the salts thereof | |
| DE3174132D1 (en) | New ethenylimidazole derivatives, processes for their preparation and pharmaceutical compositions containing them; intermediates, useful in their preparation and a process for the preparation thereof | |
| ES8800167A1 (en) | A PROCEDURE FOR PREPARING IMIDAZOLE-5-CARBOXIMIDATES | |
| ES483279A1 (en) | Substituted N-pyrazolylmethyl-haloacetanilides, process for their preparation and their use as herbicides. | |
| ES8502699A1 (en) | Substituted tetrahydrothiopyran-3,5-dione-4-carboxamide. | |
| DE3169235D1 (en) | New 3h-naphtho(1,2-d)imidazoles, the process for preparing them, the compounds for use as antiinflammatory agents and compositions containing them | |
| AU554967B2 (en) | Organosilyl derivatives of piperidine, piperazine and morpholine | |
| ES463637A1 (en) | Diurethanes, process for making the same and selective herbicide composition containing same | |
| DE69006607D1 (en) | Process for the preparation of carbamates and intermediates that occur. | |
| ES490675A0 (en) | A PROCEDURE FOR THE PREPARATION OF NEW OXAZOLINE AND THIAZOLINE DERIVATIVES | |
| CH653840GA3 (en) | Process for protecting keratin-containing materials from attack by keratin-eating insects and 5-phenylcarbamoylbarbituric acid compounds | |
| IE45241L (en) | BENZ [g] ISOQUINOLINE DERIVATIVES | |
| ZA825079B (en) | Substituted phenyl-cyclopropanecarboxylic acid esters,a process for their preparation,and their use as pest-combating agents |